ATE511651T1 - Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen - Google Patents

Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen

Info

Publication number
ATE511651T1
ATE511651T1 AT07007262T AT07007262T ATE511651T1 AT E511651 T1 ATE511651 T1 AT E511651T1 AT 07007262 T AT07007262 T AT 07007262T AT 07007262 T AT07007262 T AT 07007262T AT E511651 T1 ATE511651 T1 AT E511651T1
Authority
AT
Austria
Prior art keywords
transglutaminase
autoimmune diseases
diagnostic indicator
novel antigen
diagnostic
Prior art date
Application number
AT07007262T
Other languages
English (en)
Inventor
Daniel Aeschlimann
Marios Hadjivassilliou
Original Assignee
Zedira Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zedira Gmbh filed Critical Zedira Gmbh
Application granted granted Critical
Publication of ATE511651T1 publication Critical patent/ATE511651T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1025—Acyltransferases (2.3)
    • C12N9/104—Aminoacyltransferases (2.3.2)
    • C12N9/1044—Protein-glutamine gamma-glutamyltransferase (2.3.2.13), i.e. transglutaminase or factor XIII
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/91—Transferases (2.)
    • G01N2333/91045—Acyltransferases (2.3)
    • G01N2333/91074—Aminoacyltransferases (general) (2.3.2)
    • G01N2333/9108—Aminoacyltransferases (general) (2.3.2) with definite EC number (2.3.2.-)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/24—Immunology or allergic disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • General Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT07007262T 2007-04-06 2007-04-06 Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen ATE511651T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07007262A EP1978364B1 (de) 2007-04-06 2007-04-06 Transglutaminase 6 als diagnostischer Indikator für Autoimmunerkrankungen

Publications (1)

Publication Number Publication Date
ATE511651T1 true ATE511651T1 (de) 2011-06-15

Family

ID=38158045

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07007262T ATE511651T1 (de) 2007-04-06 2007-04-06 Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen

Country Status (7)

Country Link
US (1) US20130196336A1 (de)
EP (1) EP1978364B1 (de)
AT (1) ATE511651T1 (de)
AU (1) AU2008234999A1 (de)
CA (1) CA2683394A1 (de)
RU (1) RU2009140980A (de)
WO (1) WO2008122432A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU0900195D0 (en) * 2009-04-01 2009-06-29 Debreceni Egyetem Diagnosis and treatment of gluten-induced autoimmune diseases
HU0900199D0 (en) * 2009-04-01 2009-06-29 Debreceni Egyetem Diagnosis of gluten-induced autoimmune diseases
EP2322926A1 (de) * 2009-11-11 2011-05-18 Zedira GmbH Stabilisiertes Transglutaminase als diagnostischer Indikator für Autoimmunerkrankungen
WO2011057826A1 (en) * 2009-11-11 2011-05-19 Zedira Gmbh Stabilized open form transglutaminase as a diagnostic indicator for autoimmune diseases
JP2013528799A (ja) * 2010-05-13 2013-07-11 ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー 神経変性疾患の検知および診断のための診断用自己抗体プロファイル
CN102220337B (zh) * 2010-09-19 2012-11-14 中南大学 一种遗传性脊髓小脑共济失调相关基因
RU2441240C1 (ru) * 2010-10-05 2012-01-27 Государственное образовательное учреждение высшего профессионального образования "Московский государственный медико-стоматологический университет" Министерства здравоохранения и социального развития Российской Федерации Способ диагностики аксонально-демиелинизирующих полиневропатий
CN107831318B (zh) * 2011-01-20 2021-06-18 西瑞斯实验室有限公司 检测谷蛋白敏感性和其区分于乳糜泻的方法和装置
WO2013010003A1 (en) 2011-07-12 2013-01-17 University Of Medicine And Dentistry Of New Jersey Diagnostic biomarker profiles for the detection and diagnosis of alzheimer's disease
EP3260864B1 (de) * 2016-06-21 2024-08-07 Euroimmun Medizinische Labordiagnostika AG Diagnostischer co-inkubations-assay
IT202100019616A1 (it) * 2021-07-23 2023-01-23 Univ Degli Studi Di Trieste Nuovo metodo
CN116515786B (zh) * 2023-04-26 2024-05-28 广东医科大学 一种人tgm3乙酰化多肽、抗原、抗体及其制备方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19630557C2 (de) 1996-07-18 1998-07-02 Schuppan Detlef Priv Doz Dr Dr Verfahren zum Nachweis von Antikörpern aus Körperflüssigkeiten durch eine Immunreaktion mit Gewebe-Transglutaminase (tTG) sowie die Verwendung von tTG in Diagnose und Therapie
ATE269543T1 (de) 1999-06-28 2004-07-15 Immundiagnostik Ag Diagnose der glutensensibilitätsenteropathie und anderer autoimmunerkrangungen
ATE449180T1 (de) 2000-09-15 2009-12-15 Zedira Gmbh Transglutaminase genprodukte
GB0103024D0 (en) * 2001-02-07 2001-03-21 Rsr Ltd Assay for Autoantibodies to tissue transglutaminase

Also Published As

Publication number Publication date
EP1978364B1 (de) 2011-06-01
RU2009140980A (ru) 2011-05-20
EP1978364A1 (de) 2008-10-08
WO2008122432A1 (en) 2008-10-16
CA2683394A1 (en) 2008-10-16
AU2008234999A1 (en) 2008-10-16
US20130196336A1 (en) 2013-08-01

Similar Documents

Publication Publication Date Title
ATE511651T1 (de) Transglutaminase 6 als diagnostischer indikator für autoimmunerkrankungen
EA201100231A1 (ru) Диагностический анализ на основе антител
DE602007011566D1 (en) Ankheit
WO2007117444A3 (en) Protein detection by aptamers
EP3070474A3 (de) Verfahren und zusammensetzungen zur diagnose und prognose von nierenläsion und niereninsuffizienz
EP2516681A4 (de) Zusammensetzungen und verfahren zur erkennung kleiner rnas
DE602006007703D1 (de) Verbesserte immuntestverfahren
CA2839777C (en) Methods for the prognostic and/or diagnostic of neurodegenerative disease, methods to identify candidate compounds and compounds for treating neurodegenerative disease
BR112014013082A2 (pt) método para detectar adutos nucleossomos
KR100971305B9 (ko) 신장 질환용 진단 표지로서의 호중구 젤라티나제 결합리포칼린 의 측정
EA201390150A1 (ru) Способы выявления сигнатур заболевания или патологических состояний в текучих средах организма
WO2008148072A3 (en) Disease-associated genetic variations and methods for obtaining and using same
EA201001874A1 (ru) Способ диагностики злокачественных новообразований, экспрессирующих рецептор her2 или его укороченные варианты
WO2007147074A3 (en) Use of highly parallel snp genotyping for fetal diagnosis
EP2757160A3 (de) Genexpressionsmarker für Morbus Crohn
NO20070949L (no) Transkriptomdiagnostikk i spytt
EA201370063A1 (ru) Фосфолипидом рака
CY1123265T1 (el) Μια αναλυση κυτταρικως μεσολαβουμενης ανοσοαποκρισhς
WO2010041149A3 (en) Methods and compositions for diagnosis and treatment of autoimmune disease secondary to multiple sclerosis
WO2006134390A3 (en) Method for diagnosing neurodegenerative disease
MX336280B (es) Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal.
EP1883816A4 (de) Diagnosevorrichtung zur messung des verhältnisses von proteinen mit ähnlicher struktur
WO2018038352A3 (ko) 치매진단용 자가항체 바이오마커 및 이를 이용한 치매진단 방법
WO2007119111A3 (en) Tissue diagnostics for ovarian cancer
MX339765B (es) Metodos y composiciones para diagnostico y pronostico de lesion renal y falla renal.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties